Severe course of HIV-related Kaposi’s sarcoma with cutaneous, visceral and oral manifestations in a late-presenting patient
DOI:
https://doi.org/10.56782/pps.188Keywords:
HIV, AIDS, Kaposi’s sarcoma, HHV-8, chemotherapyAbstract
Kaposi’s sarcoma is a soft tissue tumor caused by human herpesvirus 8 (HHV-8). One of its forms is associated with human immunodeficiency virus (HIV) and is characterized by involvement of the skin and internal organs. We present a case of a 42-year-old male diagnosed with acquired immunodeficiency syndrome (AIDS) and disseminated Kaposi’s sarcoma with cutaneous, oral and visceral manifestations. During the months of hospitalization the patient suffered from neutropenic fever, gastrointestinal bleedings and required multiple blood transfusions. The patient was started on antiretroviral treatment followed by chemotherapy with paclitaxel. The skin lesions regressed, the patient gained weight and there was an improvement in performance status. This case demonstrates how severe HIV-related Kaposi’s sarcoma can be and the effectiveness of antiretroviral treatment combined with chemotherapy in combating the disease. The authors believe that great effort must be made to prevent new HIV infections and all the negative implications that may follow.
Downloads
References
Bishop, BN; Lynch, D.T. Kaposi Sarcoma. StatPearls. Published online June 5, 2023. Accessed September 5, 2023. https://www.ncbi.nlm.nih.gov/books/NBK534839/
Tounouga, D.N., Kouotou, E.A.; Nansseu, J.R.; Zoung-Kanyi Bissek, A.C. Epidemiological and Clinical Patterns of Kaposi Sarcoma: A 16-Year Retrospective Cross-Sectional Study from Yaoundé, Cameroon. Dermatology 2018, 234(5-6), 226-228. doi:10.1159/000492175 DOI: https://doi.org/10.1159/000492175
Thieringer, F.M.; Cede, J.; Glatz, K.; Roehling, S.; Stoeckle, M.; Leiggener, C.S. Oral Kaposi’s Sarcoma: A Case Report and Literature Review on Treatment Management. Craniomaxillofac. Trauma Reconstr. 2021, 6. doi:10.1177/24727512211036328 DOI: https://doi.org/10.1177/24727512211036328
Hoffmann, C.; Sabranski, M.; Esser S. HIV-Associated Kaposi’s Sarcoma. Oncol. Res. Treat. 2017, 40(3), 94-98. doi:10.1159/000455971 DOI: https://doi.org/10.1159/000455971
Azam, F.; Latif, M.F.; Farooq, A.; et al. Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals. Case Rep. Oncol. 2019, 12(3), 728-736. doi:10.1159/000503095 DOI: https://doi.org/10.1159/000503095
Miranda, M.N.S.; Pingarilho, M.; Pimentel, V.; et al. Determinants of HIV-1 Late Presentation in Patients Followed in Europe. Pathogens 2021, 10(7), Art. No: 835. doi:10.3390/PATHOGENS10070835 DOI: https://doi.org/10.3390/pathogens10070835
The Late Presentation Working Groups in EuroSIDA and COHER. Estimating the burden of HIV late presentation and its attributable morbidity and mortality across Europe 2010-2016. BMC Infect. Dis. 2020, 20(1), Art. No: 728. https://doi.org/10.1186/s12879-020-05261-7 DOI: https://doi.org/10.1186/s12879-020-05261-7
Liu, Z.; Fang, Q.; Zuo, J.; Minhas, V.; Wood, C.; Zhang, T. The world-wide incidence of Kaposi’s sarcoma in the HIV/AIDS era. HIV Med. 2018, 19(5), 355-364. doi:10.1111/HIV.12584 DOI: https://doi.org/10.1111/hiv.12584
Lemlich, G.; Schwam, L.; Lebwohl, M. Kaposi’s sarcoma and acquired immunodeficiency syndrome. Postmortem findings in twenty-four cases. J. Am. Acad. Dermatol. 1987, 16 (2 Pt 1), 319-325. doi:10.1016/S0190-9622(87)70043-7 DOI: https://doi.org/10.1016/S0190-9622(87)70043-7
DiNenno, E.A., Prejean, J.; Irwin, K.; et al. Recommendations for HIV Screening of Gay, Bisexual, and Other Men Who Have Sex with Men - United States, 2017. MMWR Morb. Mortal. Wkly Rep. 2017, 66(31), 830-832. doi:10.15585/MMWR.MM6631A3 DOI: https://doi.org/10.15585/mmwr.mm6631a3
Wurm, M.; Neumann, A.; Wasem, J.; Biermann-Stallwitz, J. Zugangsschwellen zu HIV-Test-Angeboten – Eine systematische Literaturanalyse [Barriers to Accessing HIV Testing Services - A Systematic Literature Review] Gesundheitswesen 2019, 81(3), E43-E57. doi:10.1055/A-0668-5621 DOI: https://doi.org/10.1055/a-0668-5621
Ramaswami, R.; Lurain, K.; Yarchoan, R. Oncologic Treatment of HIV-Associated Kaposi Sarcoma 40 Years on. J. Clin. Oncol. 2022, 40(3), 294-306. doi:10.1200/JCO.21.02040 DOI: https://doi.org/10.1200/JCO.21.02040
Arul, A.S.K.J.; Kumar, A.R.; Verma, S.; Arul, A.S.S.J. Oral Kaposi’s sarcoma: Sole presentation in HIV seropositive patient. J. Nat. Sci. Biol. Med. 2015, 6(2), 459-461. doi:10.4103/0976-9668.160041 DOI: https://doi.org/10.4103/0976-9668.160041
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Szymon Barczak, Barbara Badura, Agnieszka Lembas, Tomasz Mikuła, Alicja Wiercińska-Drapało
This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
How to Cite
